Literature DB >> 15475095

Fluid administration during abdominal surgery influences on coagulation in the postoperative period.

Michal Barak1, Michael Rudin, Oded Vofsi, Alex Droyan, Yeshayahu Katz.   

Abstract

OBJECTIVE: Postoperative coagulopathy is an important concern for patients after major surgery. Our objective was to define the factors that correlate with postoperative deterioration in coagulation.
DESIGN: Retrospective clinical case study.
SETTING: University hospital. PARTICIPANTS: Adult patients (n = 150), who underwent major abdominal surgery, were randomly chosen to participate in the study. For each patient, demographic and medical data, anesthetic information, type and duration of surgery, hemodynamic variables, fluid administration, as well as preoperative and postoperative prothrombin time and partial thromboplastin time were collected. Statistical analysis was used to determine which factors correlated with deterioration of coagulation tests.
RESULTS: We found statistically significant correlation between deteriorating coagulation functions and administration of more than 3 l of crystalloids during abdominal surgery. There was also correlation between administration of more than 500 ml of colloid administration and elongation of protrombin time. The remainder of the above studied factors did not correlate with deteriorating coagulation.
CONCLUSIONS: Administration of more than 3-l crystalloids or 500-ml colloids during abdominal surgery correlates with postoperative coagulopathy.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15475095     DOI: 10.1016/j.cursur.2004.02.002

Source DB:  PubMed          Journal:  Curr Surg        ISSN: 0149-7944


  9 in total

1.  Substantial variation of both opinions and practice regarding perioperative fluid resuscitation.

Authors:  Peter C Chong; Elisa F Greco; Danielle Stothart; Donna E Maziak; Sudhir Sundaresan; Farid M Shamji; David Neilipovitz; Lauralyn McIntyre; Paul Hébert; Andrew J E Seely
Journal:  Can J Surg       Date:  2009-06       Impact factor: 2.089

Review 2.  0.9% saline is neither normal nor physiological.

Authors:  Heng Li; Shi-ren Sun; John Q Yap; Jiang-hua Chen; Qi Qian
Journal:  J Zhejiang Univ Sci B       Date:  2016-03       Impact factor: 3.066

3.  Hypotensive Resuscitation.

Authors:  Jeremy B Smith; Jean-Francois Pittet; Albert Pierce
Journal:  Curr Anesthesiol Rep       Date:  2014-09-01

4.  Changing epidemiology of trauma deaths leads to a bimodal distribution.

Authors:  Mark Gunst; Vafa Ghaemmaghami; Amy Gruszecki; Jill Urban; Heidi Frankel; Shahid Shafi
Journal:  Proc (Bayl Univ Med Cent)       Date:  2010-10

5.  HIPEC as a risk factor for postoperative coagulopathy after cytoreductive surgery for peritoneal metastases.

Authors:  Antonio Sommariva; Marco Tonello; Emanuele Migliori; Elisa Pizzolato; Carola Cenzi; Marica Mirabella; Pierluigi Pilati
Journal:  Updates Surg       Date:  2022-08-06

6.  A comparative study of Sterofundin and Ringer lactate based infusion protocol in scoliosis correction surgery.

Authors:  Ashima Sharma; Monu Yadav; B Rajesh Kumar; P Sai Lakshman; Raju Iyenger; Gopinath Ramchandran
Journal:  Anesth Essays Res       Date:  2016 Sep-Dec

7.  Crystalloid resuscitation in trauma patients: deleterious effect of 5L or more in the first 24h.

Authors:  D G Jones; J Nantais; J B Rezende-Neto; S Yazdani; P Vegas; S Rizoli
Journal:  BMC Surg       Date:  2018-11-06       Impact factor: 2.102

8.  Protective effect of restrictive resuscitation on vascular endothelial glycocalyx in pigs with traumatic hemorrhagic shock.

Authors:  Yunfei Chi; Xue Jiang; Jiake Chai; Yang Chang; Tian Liu; Xiangyu Liu; Jianxiang Huang; Bin Wei; Jinguang Zheng; Xingxia Hao; Hailiang Bai; Yirui Qu; Fangchao Hu; Shaofang Han; Qiushuang Wang
Journal:  Ann Transl Med       Date:  2022-02

9.  Postoperative outcomes based on crystalloid administration in pediatric patients with necrotizing enterocolitis undergoing laparotomy.

Authors:  Xin Xie; Siyuan Guo; Chun Deng; Chunbao Guo
Journal:  Medicine (Baltimore)       Date:  2020-10-02       Impact factor: 1.817

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.